🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Fatigue is one of the most prevalent and disabling symptoms of multiple scl...
Status
Completed
Location
Tanner Foundation
Start Date
2020-02-17
Trial ID
NCT04002102
Treatments Being Tested
Persistent opioid abuse presents a common yet under-recognized problem give...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-12
Trial ID
NCT04883983
Treatments Being Tested
To compare the efficacy of inebilizumab (MEDI-551) versus placebo in reduci...
Status
Completed
Location
Research Site
Start Date
2015-04-01
Trial ID
NCT02200770
Treatments Being Tested
Treating Oral Lichen Planus (OLP) is a big challenge for clinicians. Despit...
Status
Completed
Location
Multiple Locations
Start Date
2016-12-27
Trial ID
NCT03572959
Treatments Being Tested
The purpose of this study is to understand the effects of long-term treatme...
Status
Active Not Recruiting
Location
Wayne State University School of Medicine
Start Date
2024-04-02
Trial ID
NCT06180278
Treatments Being Tested
Major depressive disorder (MDD) is the current leading cause of disability ...
Status
Terminated
Location
UCSF
Start Date
2020-05-14
Trial ID
NCT04201106
Treatments Being Tested
Lichen planus is a chronic inflammatory dermatosis. It most often affects t...
Status
Completed
Location
Wroclaw Medical University
Start Date
2020-12-10
Trial ID
NCT04976673
Treatments Being Tested
Oral lichen planus patients who will meet inclusion criteria will be divide...
Status
Unknown
Location
Cairo University
Start Date
2023-05-01
Trial ID
NCT06119672
Treatments Being Tested
Bromelain, an enzyme extract derived from pineapples, has shown promise due...
Status
Recruiting
Location
Cairo University
Start Date
2026-02-18
Trial ID
NCT06981767
The primary purpose of this study is to evaluate the efficacy of ublituxima...
Status
Recruiting
Location
TG Therapeutics Investigational Trial Site
Start Date
2026-07-30
Trial ID
NCT07673744
Treatments Being Tested